Steven Pulley, MD
Interventional Pain Medicine · Pearland, TXNPI 1104037878
Payments from drug & device makers
Across 211 payments — averaging $13.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$1000
- AbbVie$305
- Medtronic$285
- Amgen$134
- Pfizer$123
- Lundbeck LLC$119
- plus $799 from 23 others
What the payments were for
- Food & beverage$2,765100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 91 | $1,000 |
| AbbVie(2 entities) | 14 | $305 |
| Medtronic | 33 | $285 |
| Amgen | 8 | $134 |
| Pfizer | 9 | $123 |
| Lundbeck LLC | 7 | $119 |
| Biodelivery Sciences International, Inc. | 6 | $97 |
| Idorsia Pharmaceuticals US Inc | 5 | $75 |
| Nevro Corp. | 3 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Tersera Therapeutics LLC | 2 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Relievant Medsystems, Inc. | 3 | $41 |
| Nalu Medical, Inc. | 2 | $40 |
| Arbor Pharmaceuticals, Inc. | 3 | $39 |
| Shionogi Inc | 2 | $38 |
| Almatica Pharma LLC | 1 | $32 |
| GRT US Holding, Inc. | 2 | $29 |
| Eisai Inc. | 2 | $29 |
| Virtus Pharmaceuticals LLC | 2 | $28 |
| Boston Scientific | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $14 |
| Upsher-smith Laboratories LLC | 1 | $14 |
| MDD US Operations, LLC | 1 | $14 |
| Indivior Inc. | 1 | $14 |
| AstraZeneca | 1 | $12 |
| Stimwave Technologies Incorporated | 1 | $11 |
How this compares
$2,765 in reported general payments places this provider in the 30th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $1,458 |
| Oxycodone Hcl | 50 | $1,210 |
| Pregabalin | 29 | $1,160 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $797 |
| Gabapentin | 17 | $200 |
| Ondansetron OdtOndansetron | 14 | $185 |
| Cyclobenzaprine Hcl | 15 | $109 |
| Trazodone Hcl | 15 | $55 |
| Diazepam | 30 | $26 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Pearland
- Jay LafleurPearland$147K
- David NguyenPearland$129K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.2M
- Genaro GutierrezAustin$1.3M
- Chad StephensSouthlake$1.1M
- Ioannis SkaribasHouston$979K
- Duane GriffithTyler$730K
- Brannon FrankAustin$698K
- Robert WillsRound Rock$692K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.